Breakthrough Drug Delivery System Targets Brain Cancer
突破性藥物傳輸系統瞄準腦癌
更新於: 2026年6月9日 上午01:45
Treating malignant brain tumors like glioblastoma has long been a major medical challenge, primarily due to the blood-brain barrier (BBB).
治療惡性腦腫瘤,如膠質母細胞瘤,長期以來一直是醫學上的重大挑戰,主要是因為血腦屏障(BBB)的存在。
Researchers are now using nanotechnology, such as specialized nanoparticles and liposomes, to improve drug stability and precision.
研究人員目前正利用奈米技術,例如專門的奈米顆粒和脂質體,來提高藥物的穩定性和精確度。
These systems are becoming increasingly versatile, capable of carrying not only chemotherapy but also gene-editing tools like CRISPR and immunotherapies.
這些系統變得越來越靈活,不僅能攜帶化療藥物,還能攜帶如CRISPR等基因編輯工具及免疫療法藥劑。
By moving away from blunt, systemic treatments toward intelligent, stimuli-responsive delivery, medicine is getting closer to effectively reaching the heart of brain cancer.
透過從粗糙的系統性治療轉向智慧型、刺激響應式的輸送,醫學正越來越接近有效深入腦癌核心的目標。
